We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Incisionless Surgery Shows Promise in Prostate Cancer Treatment

By HospiMedica International staff writers
Posted on 16 Aug 2010
A new surgical procedure for the treatment of prostate cancer uses surgical instruments inserted through the penis, signaling the next step in the evolution of minimally invasive surgery. More...


Researchers at the Mayo Clinic (Scottsdale, AZ, USA) have developed special tools to allow natural orifice transluminal endoscopic surgical (NOTES) removal of the prostate, naming the procedure NOTES radical prostatectomy (NOTES RP). The instruments are inserted through the urethra, and an innovative technique is used to remove the entire prostate. Surgeons then rejoin the internal tissues via specialized instruments that are also designed to work through the urethra. Patients benefit from the procedure because there are no incisions, little risk of bleeding, and are usually able to leave the hospital within 24 hours.

The procedure involves a 100 W holmium:yttrium-aluminum-garnet laser with a 550 μm end-firing laser fiber, a 26F resectoscope, a 7F laser stabilizing catheter, and continuous irrigation. The surgeons first radically resect the prostate with the lasers; the tissue is then removed endoscopically with a tissue morcellator and delivered into the bladder. The first patient to undergo the NOTES RP procedure at the Mayo Clinic was released in June 2010, and suffered no complications throughout any part of the operation.

"The reason this hasn't been done in prostate surgery before is because of the challenge of rejoining or suturing the bladder back to the urethra,” said urologist Mitchell Humphreys, M.D., of the Mayo Clinic. "This really shows that the impossible is now possible, and represents a paradigm shift not only in the way we look at diseases, but also how we surgically treat disease.”

Standard surgical therapy for prostate cancer--one of the most commonly diagnosed malignancies in men--involves removal of the prostate through open, laparoscopic, or robot-assisted laparoscopic means. Each of these approaches involves removes the entire prostate, and presumably the cancer, and then suturing the bladder back to the urethra to restore the continuity of the urinary system.

Related Links:
Mayo Clinic


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Rapid Sepsis Test
SeptiCyte RAPID
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.